Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

SCLC × apatinib × Thoracic × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 21 Small Cell Lung Carcinoma 18 Lung Neoplasms 9 Neoplasms 4 NSCLC 3 Adenocarcinoma of Lung 3 Thoracic Neoplasms 2 Respiratory Tract Diseases 2 Lung Diseases 2 Advanced Non-squamous Non-small-cell Lung Cancer 2 Uterine Cervical Neoplasms 1 Stomach Neoplasms 1 Small Cell Lung Cancer Limited Stage 1 Small Cell Lung Cancer Extensive Stage 1 SCLC 1 Parkinson Disease 4, Autosomal Dominant Lewy Body 1 PD-L1 Positive Non-small Cell Lung Cancer 1 Ovarian Neoplasms 1 Extensive Stage Small Cell Lung Cancer 1 Esophageal Neoplasms 1 Breast Neoplasms 1

Interventions

Paclitaxel 2 Etoposide 2 Carboplatin 2 sintilimab 1 pembrolizumab 1 olaparib 1 ceralasertib 1 atezolizumab 1 apatinib 1 Topotecan 1 Platinum 1 Immune Checkpoint Inhibitors 1 Drug Therapy 1 Cisplatin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06475209 2024-06-26

Adebrelimab + Apatinib in SCLC Maintenance Therapy

Tang-Du Hospital

Phase 2 Recruiting

SCLC

Data powered by HemOnc (CC BY 4.0) Colophon ⚡